Brooks Laboratories Limited (BROOKS.NS)
INR 156.86
(2.0%)
INR 156.86
(2.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -72.25 Million INR | 104.32% |
| 2022 | -334.02 Million INR | -56.23% |
| 2021 | -213.79 Million INR | -225.6% |
| 2020 | -65.66 Million INR | 26.75% |
| 2019 | -89.64 Million INR | 25.21% |
| 2018 | -119.84 Million INR | 21.84% |
| 2017 | -153.34 Million INR | -600.9% |
| 2016 | 30.61 Million INR | -71.7% |
| 2015 | 108.18 Million INR | 4.53% |
| 2014 | 103.5 Million INR | 36.7% |
| 2013 | 75.71 Million INR | -20.99% |
| 2012 | 95.82 Million INR | 4.5% |
| 2011 | 91.69 Million INR | 25.68% |
| 2010 | 72.96 Million INR | 32.92% |
| 2009 | 54.89 Million INR | 71.29% |
| 2008 | 32.04 Million INR | -18.29% |
| 2007 | 39.22 Million INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -1.2 Million INR | -6391.7% |
| 2023 Q3 | -36.39 Million INR | -150.95% |
| 2023 FY | 14.44 Million INR | 104.32% |
| 2023 Q2 | -14.5 Million INR | -248.32% |
| 2023 Q1 | -4.16 Million INR | 3.77% |
| 2023 Q4 | -759 Thousand INR | 97.91% |
| 2022 Q2 | -111.03 Million INR | -5.27% |
| 2022 Q4 | -4.32 Million INR | 95.99% |
| 2022 Q1 | -105.47 Million INR | -90.73% |
| 2022 FY | -334.02 Million INR | -56.23% |
| 2022 Q3 | -107.87 Million INR | 2.84% |
| 2021 Q1 | -21.52 Million INR | 61.84% |
| 2021 Q2 | -63.33 Million INR | -194.28% |
| 2021 Q3 | -82.64 Million INR | -30.49% |
| 2021 Q4 | -55.29 Million INR | 33.09% |
| 2021 FY | -213.79 Million INR | -225.6% |
| 2020 Q3 | -23.82 Million INR | -165.37% |
| 2020 Q4 | -56.4 Million INR | -136.69% |
| 2020 Q2 | 36.45 Million INR | 264.03% |
| 2020 Q1 | -22.22 Million INR | -54.24% |
| 2020 FY | -65.66 Million INR | 26.75% |
| 2019 Q3 | -25.73 Million INR | 27.17% |
| 2019 FY | -89.64 Million INR | 25.21% |
| 2019 Q2 | -35.32 Million INR | -108.12% |
| 2019 Q1 | -16.97 Million INR | -33.22% |
| 2019 Q4 | -14.4 Million INR | 44.0% |
| 2018 Q2 | -30.61 Million INR | 41.55% |
| 2018 Q4 | -12.74 Million INR | 50.62% |
| 2018 FY | -119.84 Million INR | 21.84% |
| 2018 Q1 | -52.37 Million INR | -56.19% |
| 2018 Q3 | -25.8 Million INR | 15.7% |
| 2017 Q2 | -48.08 Million INR | 11.5% |
| 2017 FY | -153.34 Million INR | -600.9% |
| 2017 Q4 | -33.53 Million INR | -0.58% |
| 2017 Q3 | -33.33 Million INR | 30.67% |
| 2017 Q1 | -54.33 Million INR | -334.17% |
| 2016 Q1 | 24.48 Million INR | -33.86% |
| 2016 Q4 | -12.51 Million INR | -274.61% |
| 2016 Q3 | 7.16 Million INR | -37.51% |
| 2016 Q2 | 11.46 Million INR | -53.16% |
| 2016 FY | 30.61 Million INR | -71.7% |
| 2015 Q3 | 29.09 Million INR | 13.75% |
| 2015 Q4 | 37.02 Million INR | 27.26% |
| 2015 Q1 | 16.49 Million INR | -39.26% |
| 2015 Q2 | 25.57 Million INR | 55.02% |
| 2015 FY | 108.18 Million INR | 4.53% |
| 2014 Q4 | 27.16 Million INR | 20.43% |
| 2014 FY | 103.5 Million INR | 36.7% |
| 2014 Q1 | 14.89 Million INR | -31.41% |
| 2014 Q2 | 38.89 Million INR | 161.16% |
| 2014 Q3 | 22.55 Million INR | -42.01% |
| 2013 Q1 | 19.7 Million INR | 6.34% |
| 2013 Q3 | 14.7 Million INR | -25.0% |
| 2013 Q4 | 21.71 Million INR | 47.71% |
| 2013 FY | 75.71 Million INR | -20.99% |
| 2013 Q2 | 19.6 Million INR | -0.51% |
| 2012 Q1 | 17.7 Million INR | -14.49% |
| 2012 Q2 | 28.8 Million INR | 62.71% |
| 2012 Q3 | 30.8 Million INR | 6.94% |
| 2012 FY | 95.82 Million INR | 4.5% |
| 2012 Q4 | 18.52 Million INR | -39.85% |
| 2011 Q3 | 30.3 Million INR | 15.65% |
| 2011 Q2 | 26.2 Million INR | 0.0% |
| 2011 FY | 91.69 Million INR | 25.68% |
| 2011 Q4 | 20.69 Million INR | -31.69% |
| 2010 FY | 72.96 Million INR | 32.92% |
| 2009 FY | 54.89 Million INR | 71.29% |
| 2008 FY | 32.04 Million INR | -18.29% |
| 2007 FY | 39.22 Million INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Sigachi Industries Limited | 1.47 Billion INR | 104.902% |
| Ind-Swift Limited | 1.22 Billion INR | 105.893% |
| Bajaj HealthCare Limited | - INR | Infinity% |
| Sakar Healthcare Limited | 495.5 Million INR | 114.581% |
| Aurobindo Pharma Limited | 104.5 Billion INR | 100.069% |
| Innova Captab Limited | 2.53 Billion INR | 102.852% |
| Divi's Laboratories Limited | 18.31 Billion INR | 100.395% |
| AstraZeneca Pharma India Limited | 4.47 Billion INR | 101.615% |
| Morepen Laboratories Limited | 4.17 Billion INR | 101.731% |
| Mankind Pharma Limited | 40.86 Billion INR | 100.177% |
| Sequent Scientific Limited | - INR | Infinity% |
| Wanbury Limited | 1.7 Billion INR | 104.232% |
| Laurus Labs Limited | 3.94 Billion INR | 101.83% |
| Nectar Lifesciences Limited | 3.89 Billion INR | 101.857% |
| Glenmark Life Sciences Limited | 8.97 Billion INR | 100.805% |
| Alembic Limited | 767.77 Million INR | 109.411% |
| Hikal Limited | 1.49 Billion INR | 104.835% |
| Alembic Pharmaceuticals Limited | 5.75 Billion INR | 101.255% |
| Neuland Laboratories Limited | 5.31 Billion INR | 101.359% |
| J. B. Chemicals & Pharmaceuticals Limited | 7.54 Billion INR | 100.958% |
| Glenmark Pharmaceuticals Limited | 6.5 Billion INR | 101.111% |
| IOL Chemicals and Pharmaceuticals Limited | 4.94 Billion INR | 101.462% |
| Themis Medicare Limited | 1.3 Billion INR | 105.545% |
| RPG Life Sciences Limited | 2.29 Billion INR | 103.152% |
| Zydus Lifesciences Limited | 45.39 Billion INR | 100.159% |
| Lupin Limited | 27.75 Billion INR | 100.26% |
| Amrutanjan Health Care Limited | 621.02 Million INR | 111.634% |
| Wockhardt Limited | 140 Million INR | 151.609% |
| Vaishali Pharma Limited | 6.29 Million INR | 1247.95% |
| Aarti Pharmalabs Limited | 3.12 Billion INR | 102.31% |
| Jagsonpal Pharmaceuticals Limited | 214.04 Million INR | 133.756% |
| Jubilant Pharmova Limited | 5.18 Billion INR | 101.392% |
| FDC Limited | 3.03 Billion INR | 102.382% |
| Dr. Reddy's Laboratories Limited | 67.72 Billion INR | 100.107% |
| Kilitch Drugs (India) Limited | 208.05 Million INR | 134.728% |
| Eris Lifesciences Limited | 5.18 Billion INR | 101.394% |
| Venus Remedies Limited | 534.65 Million INR | 113.514% |
| ZIM Laboratories Limited | 1.09 Billion INR | 106.58% |
| Bliss GVS Pharma Limited | 1.23 Billion INR | 105.869% |
| Par Drugs and Chemicals Limited | 551.58 Million INR | 113.099% |
| Caplin Point Laboratories Limited | 7.22 Billion INR | 101.0% |
| Shilpa Medicare Limited | 3.76 Billion INR | 101.921% |
| Albert David Limited | 1.33 Billion INR | 105.414% |
| Ajanta Pharma Limited | 19.67 Billion INR | 100.367% |
| Hester Biosciences Limited | 364.77 Million INR | 119.808% |
| Suven Pharmaceuticals Limited | 4.6 Billion INR | 101.568% |
| Solara Active Pharma Sciences Limited | -3.85 Billion INR | 98.125% |
| Gufic Biosciences Limited | 2.89 Billion INR | 102.497% |
| Windlas Biotech Limited | 1.29 Billion INR | 105.563% |
| Procter & Gamble Health Limited | 2.78 Billion INR | 102.593% |
| Aarey Drugs & Pharmaceuticals Limited | 2.83 Million INR | 2652.329% |
| Mangalam Drugs & Organics Limited | 27.45 Million INR | 363.136% |
| Granules India Limited | 6.52 Billion INR | 101.107% |
| Aarti Drugs Limited | 7.14 Billion INR | 101.011% |
| Bal Pharma Limited | 214.56 Million INR | 133.673% |
| Alkem Laboratories Limited | 19.46 Billion INR | 100.371% |
| Sun Pharmaceutical Industries Limited | 104.3 Billion INR | 100.069% |
| Lincoln Pharmaceuticals Limited | 1.9 Billion INR | 103.79% |
| Medicamen Biotech Limited | - INR | Infinity% |
| Unichem Laboratories Limited | - INR | Infinity% |
| Bafna Pharmaceuticals Limited | 237.66 Million INR | 130.401% |
| Biofil Chemicals and Pharmaceuticals Limited | 20.65 Million INR | 449.787% |
| Valiant Laboratories Limited | - INR | Infinity% |
| Orchid Pharma Limited | 2.36 Billion INR | 103.06% |
| Medico Remedies Limited | 277.11 Million INR | 126.073% |
| Ind-Swift Laboratories Limited | 2 Billion INR | 103.596% |
| Ipca Laboratories Limited | 29.59 Billion INR | 100.244% |
| Syncom Formulations (India) Limited | 249.25 Million INR | 128.988% |
| Piramal Enterprises Limited | - INR | Infinity% |
| Torrent Pharmaceuticals Limited | 25.33 Billion INR | 100.285% |
| NATCO Pharma Limited | 25.96 Billion INR | 100.278% |
| Suven Life Sciences Limited | -1.22 Billion INR | 94.106% |
| Krebs Biochemicals & Industries Limited | - INR | Infinity% |
| Strides Pharma Science Limited | 5.22 Billion INR | 101.383% |
| Indoco Remedies Limited | 1.52 Billion INR | 104.74% |
| Alpa Laboratories Limited | 61.51 Million INR | 217.454% |
| Lasa Supergenerics Limited | -458 Million INR | 84.225% |
| Sun Pharma Advanced Research Company Limited | -4.11 Billion INR | 98.244% |